Is there a benefit of aspirin therapy for primary prevention to reduce the risk of atherosclerotic cardiovascular disease in patients with elevated Lipoprotein (a)-A review of the evidence.

Am J Prev Cardiol · 2023 · PMC10509658 · PMID 37736358

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

There are a few small studies that have shown a quite significant Lp(a) lowering effect of aspirin therapy [ 18 , 19 ] with a wide range of effect size.

also in 5,705 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.